Reperfusate composition: interaction of marked hyperglycemia and marked hyperosmolarity in allowing immediate contractile recovery after four hours of regional ischemia
- PMID: 3747586
Reperfusate composition: interaction of marked hyperglycemia and marked hyperosmolarity in allowing immediate contractile recovery after four hours of regional ischemia
Abstract
This study tests the hypothesis that improved muscle salvage after prolonged ischemia (4 hours) occurs when the substrate-enriched blood cardioplegic solution is markedly hyperglycemic (greater than 400 mg/dl) and markedly hyperosmotic (greater than 400 mOsm). Thirty-five dogs underwent 4 hours of occlusion of the left anterior descending coronary artery and reperfusion during total vented bypass with substrate-enriched blood cardioplegic solution, in which the glucose concentration and osmolarity were varied in relation to one another. Spontaneous systolic shortening recovered consistently (31 +/- 6%) only when glucose was greater than 400 mg/dl and osmolarity was greater than 400 mOsm. The least recovery occurred (only one of six dogs recovering spontaneous shortening) when cardioplegic glucose was greater than 400 mg/dl and osmolarity was greater than 400 mOsm. Regional segments reperfused with our standard substrate-enriched blood cardioplegic solution had lower transmural flow rates following reperfusion (56 versus 87 ml/100 gm/min, p less than 0.05), markedly reduced mitochondrial State 3 and State 4 respiration in epicardial and endocardial muscle (p less than 0.05), and the most extensive histochemical evidence of damage (63% area of nonstaining versus area at risk, p less than 0.05). We conclude that markedly increased levels of osmolarity (greater than 400 mOsm) and glucose (greater than 400 mg/dl) improve the capacity of substrate-enriched blood cardioplegic solution to salvage myocardium after prolonged ischemia.
Similar articles
-
Immediate functional recovery after six hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate.J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):621-35. J Thorac Cardiovasc Surg. 1986. PMID: 2875224
-
Reperfusate composition: benefits of marked hypocalcemia and diltiazem on regional recovery.J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):564-72. J Thorac Cardiovasc Surg. 1986. PMID: 3747584
-
Reperfusion conditions: critical importance of total ventricular decompression during regional reperfusion.J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):605-12. J Thorac Cardiovasc Surg. 1986. PMID: 2875223
-
Reperfusate composition: supplemental role of intravenous and intracoronary coenzyme Q10 in avoiding reperfusion damage.J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):573-82. J Thorac Cardiovasc Surg. 1986. PMID: 3747585
-
Superiority of surgical versus medical reperfusion after regional ischemia.J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):525-34. J Thorac Cardiovasc Surg. 1986. PMID: 3747580
Cited by
-
Protection of the ischemic myocardium during the reperfusion: between hope and reality.Am J Cardiovasc Dis. 2012;2(3):223-36. Epub 2012 Jul 25. Am J Cardiovasc Dis. 2012. PMID: 22937492 Free PMC article.
-
Intestinal injury can be reduced by intra-arterial postischemic perfusion with hypertonic saline.World J Gastroenterol. 2013 Jan 14;19(2):209-18. doi: 10.3748/wjg.v19.i2.209. World J Gastroenterol. 2013. PMID: 23345943 Free PMC article.
-
Australian and New Zealand perfusion survey: management and procedure.J Extra Corpor Technol. 2009 Jun;41(2):64-72. J Extra Corpor Technol. 2009. PMID: 19681302 Free PMC article.
-
Myocardial protection during surgical intervention for treatment of acute myocardial infarction.Tex Heart Inst J. 1992;19(1):26-40. Tex Heart Inst J. 1992. PMID: 15227467 Free PMC article. No abstract available.
-
Cardiac ischemia. Part II--Reperfusion and treatment.West J Med. 1987 Jul;147(1):54-61. West J Med. 1987. PMID: 2962369 Free PMC article. Review.